HAN WHA PHARMA CO., LTD.
3Patents
3Active
3Granted
43Portfolio score
Filing activity: Dec 17, 2008 → Aug 19, 2016 · 1 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10081635B2 | Substituted N-(pyrrolidine-3-yl)-7H-pyrrolo[2,3-D]pyrimidine-4-amine as janus kinase inhibitor | Human Necessities | 1 | Active |
| US8734866B2 | Composition comprising the extracts of lindera obtusiloba for prevention and treatment of cardiovascular diseases | Human Necessities | 0 | Active |
| US10407430B2 | Janus kinase 1 selective inhibitor and pharmaceutical use thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.